Related Experiment Video
Updated: Mar 17, 2026

08:55
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
10.0K
5. Uro-Oncology Winter Congress
Summary
The 5th Uro-oncology Winter Congress convened in Skopje, focusing on advancements in diagnosing and treating urinary tract and prostate tumors. This key urologic oncology meeting fostered collaboration among Balkan specialists.
Area of Science:
- Uro-oncology
- Urologic Oncology
- Nephrology
- Oncology
Background:
- The 5th Uro-oncology Winter Congress convened in Skopje, North Macedonia, from January 30 to February 3, 2013.
- The event focused on the latest advancements in the diagnosis and treatment of urinary tract (kidney, bladder) and prostate tumors.
- It was co-organized by prominent institutions including the Macedonian Academy of Sciences and Arts and Istanbul University.
Framework:
- The Congress featured simultaneous sessions covering diverse uro-oncological issues.
- Approximately 60 presentations were delivered, alongside poster sessions and training courses.
- A significant highlight was the inaugural Balkan Urology Session, fostering regional collaboration.
Implementation:
- The event brought together around 300 participants from the Balkan region.
- Discussions centered on cutting-edge diagnostic and therapeutic strategies for uro-oncological malignancies.
- The congress facilitated knowledge exchange and professional development for urologists and oncologists.
Implications:
- The congress underscored the importance of multidisciplinary approaches in managing uro-oncological conditions.
- It highlighted the growing need for collaborative research and clinical practice among Balkan nations.
- The event served as a platform for disseminating recent findings and best practices in urologic oncology.
Related Concept Videos
Treatment Resistent Cancers
1.5K
1.5K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies
2.9K
2.9K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K

